Literature DB >> 12538879

Components of the Rb pathway are critical targets of UV mutagenesis in a murine melanoma model.

Karuppiah Kannan1, Norman E Sharpless, Jin Xu, Ronan C O'Hagan, Marcus Bosenberg, Lynda Chin.   

Abstract

Epidemiological studies support a link between melanoma risk and UV exposure early in life, yet the molecular targets of UV's mutagenic actions are not known. By using well characterized murine models of melanoma, we provide genetic and molecular evidence that identifies components of the Rb pathway as the principal targets of UV mutagenesis in murine melanoma development. In a melanoma model driven by H-RAS activation and loss of p19(ARF) function, UV exposure resulted in a marked acceleration in melanoma genesis, with nearly half of these tumors harboring amplification of cyclin-dependent kinase (cdk) 6, whereas none of the melanomas arising in the absence of UV treatment possessed cdk6 amplification. Moreover, UV-induced melanomas showed a strict reciprocal relationship between cdk6 amplification and p16(INK4a) loss, which is consistent with the actions of UV along the Rb pathway. Most significantly, UV exposure had no impact on the kinetics of melanoma driven by H-RAS activation and p16(INK4a) deficiency. Together, these molecular and genetic data identify components of the Rb pathway as critical biological targets of UV-induced mutagenesis in the development of murine melanoma in vivo.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12538879      PMCID: PMC298754          DOI: 10.1073/pnas.0336397100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

1.  Ultraviolet radiation induces p16CDKN2A expression in human skin.

Authors:  S Pavey; S Conroy; T Russell; B Gabrielli
Journal:  Cancer Res       Date:  1999-09-01       Impact factor: 12.701

Review 2.  The pathogenesis of melanoma induced by ultraviolet radiation.

Authors:  B A Gilchrest; M S Eller; A C Geller; M Yaar
Journal:  N Engl J Med       Date:  1999-04-29       Impact factor: 91.245

3.  The p16(INK4a) tumour suppressor protein inhibits alphavbeta3 integrin-mediated cell spreading on vitronectin by blocking PKC-dependent localization of alphavbeta3 to focal contacts.

Authors:  R Fåhraeus; D P Lane
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

4.  Expression of cell cycle regulators in human cutaneous malignant melanoma.

Authors:  L Tang; G Li; V A Tron; M J Trotter; V C Ho
Journal:  Melanoma Res       Date:  1999-04       Impact factor: 3.599

5.  Neonatal sunburn and melanoma in mice.

Authors:  F P Noonan; J A Recio; H Takayama; P Duray; M R Anver; W L Rush; E C De Fabo; G Merlino
Journal:  Nature       Date:  2001-09-20       Impact factor: 49.962

6.  UV fingerprint CDKN2a but no p14ARF mutations in sporadic melanomas.

Authors:  K Peris; S Chimenti; M C Fargnoli; P Valeri; H Kerl; P Wolf
Journal:  J Invest Dermatol       Date:  1999-05       Impact factor: 8.551

7.  Tumor spectrum in ARF-deficient mice.

Authors:  T Kamijo; S Bodner; E van de Kamp; D H Randle; C J Sherr
Journal:  Cancer Res       Date:  1999-05-01       Impact factor: 12.701

Review 8.  The INK4A/ARF locus and its two gene products.

Authors:  N E Sharpless; R A DePinho
Journal:  Curr Opin Genet Dev       Date:  1999-02       Impact factor: 5.578

9.  The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.

Authors:  F J Stott; S Bates; M C James; B B McConnell; M Starborg; S Brookes; I Palmero; K Ryan; E Hara; K H Vousden; G Peters
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

Review 10.  The p16INK4a/CDKN2A tumor suppressor and its relatives.

Authors:  M Ruas; G Peters
Journal:  Biochim Biophys Acta       Date:  1998-10-14
View more
  30 in total

Review 1.  Preclinical mouse cancer models: a maze of opportunities and challenges.

Authors:  Chi-Ping Day; Glenn Merlino; Terry Van Dyke
Journal:  Cell       Date:  2015-09-24       Impact factor: 41.582

2.  Loss of ARF sensitizes transgenic BRAFV600E mice to UV-induced melanoma via suppression of XPC.

Authors:  Chi Luo; Jinghao Sheng; Miaofen G Hu; Frank G Haluska; Rutao Cui; Zhengping Xu; Philip N Tsichlis; Guo-Fu Hu; Philip W Hinds
Journal:  Cancer Res       Date:  2013-05-06       Impact factor: 12.701

3.  The FBXO4 tumor suppressor functions as a barrier to BRAFV600E-dependent metastatic melanoma.

Authors:  Eric K Lee; Zhaorui Lian; Kurt D'Andrea; Richard Letrero; WeiQi Sheng; Shujing Liu; J Nathaniel Diehl; Dariusz Pytel; Olena Barbash; Lynn Schuchter; Ravi Amaravaradi; Xiaowei Xu; Meenhard Herlyn; Katherine L Nathanson; J Alan Diehl
Journal:  Mol Cell Biol       Date:  2013-09-09       Impact factor: 4.272

4.  Induction of Therapeutic Senescence in Vemurafenib-Resistant Melanoma by Extended Inhibition of CDK4/6.

Authors:  Akihiro Yoshida; Eric K Lee; J Alan Diehl
Journal:  Cancer Res       Date:  2016-03-17       Impact factor: 12.701

Review 5.  Mouse models of UV-induced melanoma: genetics, pathology, and clinical relevance.

Authors:  Chi-Ping Day; Rachel Marchalik; Glenn Merlino; Helen Michael
Journal:  Lab Invest       Date:  2017-01-16       Impact factor: 5.662

6.  Use of human tissue to assess the oncogenic activity of melanoma-associated mutations.

Authors:  Yakov Chudnovsky; Amy E Adams; Paul B Robbins; Qun Lin; Paul A Khavari
Journal:  Nat Genet       Date:  2005-06-12       Impact factor: 38.330

7.  The role of Bcl-2 family members in the progression of cutaneous melanoma.

Authors:  Jason A Bush; Gang Li
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

Review 8.  Chemoprevention of melanoma.

Authors:  Marie-France Demierre; Glenn Merlino
Journal:  Curr Oncol Rep       Date:  2004-09       Impact factor: 5.075

9.  Novel UV-induced melanoma mouse model dependent on Endothelin3 signaling.

Authors:  Ana Paula Benaduce; Deannys Batista; Gabriel Grilo; Karen Jorge; Diana Cardero; Clara Milikowski; Lidia Kos
Journal:  Pigment Cell Melanoma Res       Date:  2014-07-03       Impact factor: 4.693

Review 10.  Recent advances on skin-resident stem/progenitor cell functions in skin regeneration, aging and cancers and novel anti-aging and cancer therapies.

Authors:  Murielle Mimeault; Surinder K Batra
Journal:  J Cell Mol Med       Date:  2009-09-01       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.